Janus Henderson Group’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-109,941
| Closed | -$125K | – | 2482 |
|
|
2025
Q1 | $125K | Hold |
109,941
| – | – | ﹤0.01% | 2438 |
|
|
2024
Q4 | $200K | Hold |
109,941
| – | – | ﹤0.01% | 2428 |
|
|
2024
Q3 | $186K | Hold |
109,941
| – | – | ﹤0.01% | 2449 |
|
|
2024
Q2 | $150K | Sell |
109,941
-1,383
| -1% | -$1.89K | ﹤0.01% | 2459 |
|
|
2024
Q1 | $417K | Buy |
111,324
+48
| +0% | +$180 | ﹤0.01% | 2092 |
|
|
2023
Q4 | $1.09M | Sell |
111,276
-120
| -0.1% | -$1.18K | ﹤0.01% | 1580 |
|
|
2023
Q3 | $930K | Buy |
111,396
+135
| +0.1% | +$1.13K | ﹤0.01% | 1590 |
|
|
2023
Q2 | $1.48M | Buy |
111,261
+10,383
| +10% | +$138K | ﹤0.01% | 1404 |
|
|
2023
Q1 | $1.17M | Buy |
100,878
+63,472
| +170% | +$735K | ﹤0.01% | 1542 |
|
|
2022
Q4 | $306K | Sell |
37,406
-37,410
| -50% | -$306K | ﹤0.01% | 1969 |
|
|
2022
Q3 | $436K | Buy |
74,816
+37,386
| +100% | +$218K | ﹤0.01% | 2024 |
|
|
2022
Q2 | $166K | Sell |
37,430
-14
| -0% | -$62 | ﹤0.01% | 2367 |
|
|
2022
Q1 | $340K | Buy |
37,444
+13
| +0% | +$118 | ﹤0.01% | 2143 |
|
|
2021
Q4 | $765K | Buy |
37,431
+18,898
| +102% | +$386K | ﹤0.01% | 1633 |
|
|
2021
Q3 | $474K | Buy |
+18,533
| New | +$474K | ﹤0.01% | 1642 |
|